在2026年2月17日,随着CSL公司宣布股息,3名CSL内部人购买了92 600美元的股份。 Three CSL insiders bought $92,600 in shares on Feb. 17, 2026, as the company announced a dividend.

2026年2月17日,CSL有限公司的3名内幕者Alison Watkins、Carolyn Hewson和Samantha Lewis购买了611个股份,每股151.56澳元,共约92 600澳元。 On February 17, 2026, three CSL Limited insiders—Alison Watkins, Carolyn Hewson, and Samantha Lewis—purchased a combined 611 shares at A$151.56 per share, totaling about A$92,600. CSL是一家全球生物制药公司,报告市场上限为774.3亿美元,P/E比率为28.02,低贝塔为0.32,表明波动性较低。 CSL, a global biopharmaceutical company, reported a market cap of $77.43 billion, a P/E ratio of 28.02, and a low beta of 0.32, indicating lower volatility. 该公司向记录股东宣布了每股1.837澳元的临时红利,应于2026年4月8日支付,退股日期为3月9日,收益率为121.0%,付款比率为50.38%。 The company declared an interim dividend of A$1.837 per share, payable April 8, 2026, to shareholders of record, with an ex-dividend date of March 9, yielding 121.0% and a payout ratio of 50.38%.